Progress in animal models of age-related macular degeneration
Age related macular degeneration(ARMD)is the leading cause of blindness in people over 65 years of age. The need for research on effective treatments of ARMD has led to the development of multiple animal models. ARMD is a complex process involving interaction of age, genetic and environmental factor...
Main Authors: | Tong-Miao Wang, Bo Qin |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2019-04-01
|
Series: | Guoji Yanke Zazhi |
Subjects: | |
Online Access: | http://ies.ijo.cn/cn_publish/2019/4/201904013.pdf |
Similar Items
-
Neuroprotection for Age-Related Macular Degeneration
by: Jonathan B. Lin, MD, PhD, et al.
Published: (2022-12-01) -
Dry age-related macular degeneration - therapeutic possibilities and research directions
by: Alicja Zajdel
Published: (2022-10-01) -
Biomarkers of macular neovascularisation activity using optical coherence tomography angiography in treated stable neovascular age related macular degeneration
by: Daren Hanumunthadu, et al.
Published: (2023-02-01) -
Recent Advances in Age-Related Macular Degeneration Therapies
by: Marie Fabre, et al.
Published: (2022-08-01) -
Diurnal variation of optical coherence tomography–based macular fluid in exudative age-related macular degeneration
by: Blake H. Fortes, et al.
Published: (2023-09-01)